Cristcot is an innovative pharmaceutical company with a patented suppository drug delivery platform utilizing the 505(b)(2) regulatory pathway; targeting formulations with: 1) high volume/low competitive landscape, 2) ability to use proprietary formulations and platform technology to revitalize old, but trusted pharmaceuticals leading to extensive pipeline opportunity, and 3) relatively similar efficacy with lower dosages or improved shelf life.